HomeHealth
Vaccine trial reports strong results in late-stage study
Efficacy topped 90% across all age groups.
By Elena Rossi
Newsmonger
Published July 5, 2026Updated September 9, 2026 1 min read 14.1K views
Regulators will now review the full dataset.
Comments
Join the conversation
No comments yet. Be the first to share your thoughts.
Leave a comment
Fresh off the desk
Just in news
Economy
FG Introduces USSD Loan Platform, Allows Nigerians to Apply Without Internet
Opinion
Why Most Nigeria's Mass Communication Graduates Are Not Employable.
Politics
CSOs Challenge Judiciary to Rebuild Public Trust Through Uzodimma-Okorocha Legal Dispute
Community
Cleric Accuses Nigeria of Celebrating Illicit Wealth at Expense of Creativity
You might also like
Related stories
Health
Nigeria’s Ebola Challenge Deepens As WHO Confirms No Approved Vaccine, Specific Treatment For Bundibugyo Strain
Health
Ebola: FG Seeks Cooperation From Passengers as 44 Contacts Are Identified
Health
NAFDAC Discovers Over 20 Illegal Stores in Lagos, Seizes Fake Drinks Worth ₦2bn
Health
Congo's Deadliest Ebola Outbreak: Over 5,000 Cases Confirmed Amid Global Aid Efforts
More
From Health
Most read
Trending
Sports
Champions clinch title in dramatic extra-time finish
Business
Tech giant beats forecasts on cloud and advertising strength
Crime & Security
Cyberattack disrupts national transit ticketing system
Politics
Cabinet reshuffle brings four new faces to senior posts
Technology